Our latest news

We are proud to be leading the way in providing more patient-centric solutions for people with liver disease that helps them and their physician make informed decisions about their care.

Read our latest news to find out more about how we are helping to improve the understanding of liver disease.

New Study Shows Measurable Organ Impairment in Long COVID Patients Posted: April 26, 2021

Long COVID COVID-19 Multiorgan Impairment

Perspectum Appoints Annalisa Jenkins, MBBS, FRCP to Board of Directors Posted: April 22, 2021

News New Director

High Liver Fat (Hepatic Steatosis) Linked to Increased Risk of Hospitalization in COVID-19 Patients with Obesity Posted: March 29, 2021

COVID-19 Long COVID Fatty Liver Disease

LiverMultiScan^® shown to be the best non-invasive predictor of disease activity in autoimmune hepatitis, demonstrating its potential to influence clinical treatment Posted: March 3, 2021

New publication AIH Autoimmune hepatitis LiverMultiScan

Perspectum Lands Top Spot in Alantra Pharma Fast 50 Rankings Posted: March 1, 2021

Awards

New research demonstrates superior performance of LiverMultiScan® for identifying patients with NASH and fibrosis Posted: February 24, 2021

NASH NAFLD LiverMultiScan Liver Disease New publication

LiverMultiScan® could be an alternative to liver biopsy for NASH clinical trials. Posted: February 4, 2021

NAFLD NASH LiverMultiScan New publication ClinicalTrials

UVA Health First Hospital in the State to Offer LiverMultiScan for Non-Invasive Assessment of Liver Disease  Posted: February 2, 2021

Perspectum launches study to improve outcomes for patients with liver cancer Posted: January 14, 2021

New grant liver cancer Genetics Radiology Pathology